IL6 and juvenile idiopathic arthritis: A different hypothesis, explaining the beneficial effect ILBI had in our JIA patient, who was also receiving an IL-6 receptor antagonist, could be that laser radiation increases the blocking effect of Tocilizumab on the IL-6-regulated inflammation pathways.